Anesthetic management in corticobasal degeneration with central sleep apnea: A case report
10.17245/jdapm.2019.19.4.235
- Author:
Yoshiki SHIONOYA
1
;
Kiminari NAKAMURA
;
Katsuhisa SUNADA
Author Information
1. Department of Dental Anesthesia, The Nippon Dental University Hospital, Tokyo, Japan. ysk.shionoya@gmail.com
- Publication Type:Case Report
- Keywords:
Corticobasal Degeneration;
Laryngeal Mask Airway;
Propofol;
Sleep Apnea
- MeSH:
Airway Obstruction;
Anesthesia;
Anesthesia, General;
Anesthetics;
Cognition Disorders;
Dystonia;
Humans;
Laryngeal Masks;
Middle Aged;
Neurodegenerative Diseases;
Propofol;
Respiration;
Respiratory Insufficiency;
Sleep Apnea Syndromes;
Sleep Apnea, Central;
Tongue;
Ventilation
- From:Journal of Dental Anesthesia and Pain Medicine
2019;19(4):235-238
- CountryRepublic of Korea
- Language:English
-
Abstract:
Corticobasal degeneration (CBD) is a rare neurodegenerative disease characterized by dystonia, cognitive deficits, and an asymmetric akinetic-rigid syndrome. Little information is available regarding anesthetic management for CBD patients. Our patient was a 55-year-old man with CBD complicated by central sleep apnea (CSA). Due to the risk of perioperative breathing instability associated with anesthetic use, a laryngeal mask airway was used during anesthesia with propofol. Spontaneous respiration was stable under general anesthesia. However, respiratory depression occurred following surgery, necessitating insertion of a nasopharyngeal airway. Since no respiratory depression had occurred during maintenance of the airway using the laryngeal mask, we suspected an upper airway obstruction caused by displacement of the tongue due to residual propofol. Residual anesthetics may cause postoperative respiratory depression in patients with CBD. Therefore, continuous postoperative monitoring of SpO₂ and preparations to support postoperative ventilation are necessary.
